Alkem Laboratories Shares Worth ₹930 Crore Sold in Block Deal; Promoters Offload Stake to Mutual Funds and FIIs
मुख्य बातें
- •Promoter-linked entities sold 17.88 lakh shares of Alkem Laboratories at ₹5,200 each, totaling a ₹930 crore block deal.
- •Jayanti Sinha sold 12.38 lakh shares, while the Samprada & Nanhamati Singh Family Trust offloaded 5.5 lakh shares.
- •ICICI Prudential Mutual Fund (9.04 lakh shares) and HDFC Mutual Fund (5.1 lakh shares) were among the largest buyers.
- •The deal follows strong share price performance driven by growth in domestic formulations, margin improvement, and US business recovery.
- •Major domestic mutual funds participated, highlighting sustained institutional interest in quality healthcare stocks.
- •Promoter shareholding will decrease post-transaction, drawing investor focus on future ownership and capital structure changes.
- •Alkem Laboratories remains a leading Indian pharmaceutical company with a diversified presence in acute therapies, chronic care, and international markets.
Shares of Alkem Laboratories Ltd witnessed a significant block deal on Tuesday, with promoter-linked entities offloading a total of 17.88 lakh shares at ₹5,200 per share, amounting to a transaction value of approximately ₹930 crore. According to data from the National Stock Exchange (NSE), the block deal involved the transfer of ownership from two seller entities to a diversified group of institutional buyers, including domestic mutual funds and foreign institutional investors (FIIs).
